StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Piper Sandler Reiterates Overweight Rating on Boston Scientific (BSX), 'recent pullback in shares is overdone'
May 4, 2026 8:32 AM
Piper Sandler analyst Matt O\'Brien reiterated an Overweight rating and $90.00 price target on Boston Scientific (NYSE: BSX).The analyst commented ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
